Tirzepatide – 10mg – Vial

Tirzepatide 10mg – Injection Vial | Royal UK Pharmacy

Tirzepatide is a cutting-edge GLP-1/GIP receptor agonist developed to treat type 2 diabetes and support weight loss injection in individuals with obesity or insulin resistance. Each vial contains 10mg of Tirzepatide, formulated for subcutaneous injection, typically administered once weekly.

Tirzepatide mimics the effects of two key gut hormones: GLP-1 and GIP, which together enhance insulin sensitivity, reduce appetite, and slow gastric emptying. This dual-action mechanism makes it one of the most effective medications for blood glucose control and body weight reduction currently available. weight loss injection

✅ Key Benefits:

• Improves insulin response and glucose regulation

• Reduces body weight by suppressing appetite and slowing digestion

• Once-weekly dosing for patient convenience

• May lower cardiovascular risk factors in type 2 diabetics

Tirzepatide is prescribed under medical supervision for:

• Type 2 diabetes management

• Chronic weight management

• Off-label use in obesity and metabolic health optimization

⚠️ Legal Status in the UK:

• Prescription-Only Medicine (POM)

• Administered under guidance of a healthcare professional